SMTL ID : 6nov.1 (1 other biounit)

A Fab derived from ixekizumab

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.14 Å

Oligo State

hetero-1-1-mer

Ligands

1 x 12P: DODECAETHYLENE GLYCOL(Non-covalent)

12P.1: 10 residues within 4Å: Chain A: D.31, Y.32, H.33, Y.99, D.100, Y.101, F.102 Chain B: H.31, N.35, Y.37 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:Y.101

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Benschop, R.J. et al., Development of tibulizumab, a tetravalent bispecific antibody targeting BAFF and IL-17A for the treatment of autoimmune disease. Mabs (2019)

Release Date

2019-06-19

Peptides

Fab Heavy Chain: A
Fab Light Chain: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

Fab Heavy Chain

Fab Light Chain

Related Entries With Identical Sequence